» Articles » PMID: 29308710

Medication Adherence and Adverse Effect Profile of Antiepileptic Drugs in Nigerian Patients with Epilepsy

Overview
Date 2018 Jan 9
PMID 29308710
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Medication adherence remains a major challenge among patients with epilepsy (PWE) with the adverse effect profile of antiepileptic drugs (AEDs) as one of its main drivers.

Methods: This was a cross-sectional questionnaire-based study among PWE in selected Nigerian tertiary healthcare facilities using the Morisky Medication Adherence Scale and the Liverpool Adverse Effect Profile (LAEP).

Results: 126 PWE from four tertiary healthcare facilities were included in this study comprising of 59 (46.8%) males and 67 (53.2%) females. Carbamazepine (104/70.7%), sodium valproate (23/15.6%) and phenytoin (11/7.5%) were the most commonly prescribed AEDs. Using the Morisky Medication Adherence Scale, 17.2, 38.3 and 44.5% of patients were classified as having high, medium and low adherence, respectively. The mean LAEP score was 23.69 ± 6.07. The most common reported adverse effects among respondents were tiredness (30.4%) and headache (22.5%).

Conclusion: Medication adherence to AED was poor among patients in this study.

Citing Articles

Treatment outcome and its predictors among children with epilepsy on chronic follow-up in Ethiopia: a systematic review and meta-analysis.

Geremew G, Wassie Y, Tadesse G, Fentahun S, Yazie A, Anberbr S BMC Public Health. 2024; 24(1):3001.

PMID: 39478531 PMC: 11523642. DOI: 10.1186/s12889-024-20441-9.


Adherence to Antiepileptic Drugs among Patients Attending the Neuro Spinal Hospital in the United Arab Emirates.

Abd Wahab E, Al Omar M, Altabakha M J Pharm Bioallied Sci. 2021; 12(4):499-507.

PMID: 33679099 PMC: 7909063. DOI: 10.4103/jpbs.JPBS_367_19.


Fitness to drive in seizure and epilepsy: A protocol for Iranian clinicians.

Tabrizi N Iran J Neurol. 2020; 18(4):159-171.

PMID: 32117552 PMC: 7036044.


A retrospective study of Ganoderma Lucidum Spore Powder for patients with epilepsy.

Wang G, Li X, Cao W, Li J, Wang L Medicine (Baltimore). 2018; 97(23):e10941.

PMID: 29879039 PMC: 5999473. DOI: 10.1097/MD.0000000000010941.